Does metabolic health in overweight and obesity persist? - Individual variation and cardiovascular mortality over two decades

European Journal of Endocrinology

Volumn 175, Issue 2, 2016, Pages 133-143

  Kaur, Akaal ^a   Johnston, Desmond G ^a   Godsland, Ian F ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ERYTHROCYTE SEDIMENTATION RATE; EUROPEAN; EXERCISE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEALTH STATUS; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEUKOCYTE COUNT; LIFESTYLE; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLICALLY HEALTHY OBESITY; OBESITY; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASE; COMPLICATION; FEMALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MORTALITY; PHYSIOLOGY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; FEMALE; HEALTH STATUS; HUMANS; INSULIN; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; RISK FACTORS; TRIGLYCERIDES;

EID: 84979895570     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-16-0095     Document Type: Article

References (37)

1. Ruderman NB, Schneider SH & Berchtold P. The "metabolically-obese," normal-weight individual. American Journal of Clinical Nutrition 1981 34 1617-1621.
2. Andres R. Effect of obesity on total mortality. International Journal of Obesity 1980 4 381-386.
3. Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism 2001 50 1499-504. (doi:10.1053/meta.2001.27213)
4. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, Gaye A, Gögele M, Heier M, Hiekkalinna T et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocrine Disorders 2014 14 9. (doi:10.1186/1472-6823-14-9)
5. Pataky Z, Bobbioni-Harsch E & Golay A. Open questions about metabolically normal obesity. International Journal of Obesity 2010 34 (Supplement 2) S18-S23. (doi:10.1038/ijo.2010.235)
6. Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Reviews in Endocrine & Metabolic Disorders 2013 14 219-227. (doi:10.1007/s11154-013-9252-x)
7. Stefan N, Häring HU, Hu FB & Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes & Endocrinology 2013 1 152-162. (doi:10.1016/S2213-8587(13)70062-7)
8. Blüher M. Are metabolically healthy obese individuals really healthy? European Journal of Endocrinology 2014 171 R209-R219. (doi:10.1530/EJE-14-0540)
9. Godsland IF, Leyva F, Worthington M, Walton C & Stevenson JC. Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Journal of Internal Medicine 1998 244 33-41.
10. Kuk JL & Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009 32 2297-2299. (doi:10.2337/dc09-0574)
11. Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS & Blair SN. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. European Heart Journal 2013 34 389-397. (doi:10.1093/eurheartj/ehs174)
12. Marini MA, Frontoni S, Succurro E, Arturi F, Fiorentino TV, Sciacqua A, Perticone F & Sesti G. Differences in insulin clearance between metabolically healthy and unhealthy obese subjects. Acta Diabetologica 2014 51 257-261. (doi:10.1007/s00592-013-0511-9)
13. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 2486-2497.
14. Alberti KG, Zimmet P, Shaw J & IDF-Epidemiology-Task-Force-Consensus-Group. The metabolic syndrome - a new worldwide definition. Lancet 2005 366 1059-1062. (doi:10.1016/S0140-6736(05)67402-8)
15. Vukovic R, Milenkovic T, Mitrovic K, Todorovic S, Plavsic L, Vukovic A & Zdravkovic D. Preserved insulin sensitivity predicts metabolically healthy obese phenotype in children and adolescents. European Journal of Pediatrics 2015 174 1649-1655. (doi:10.1007/s00431-015-2587-4)
16. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J & Sowers MR. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Archives of Internal Medicine 2008 168 1617-1624. (doi:10.1001/archinte.168.15.1617)
17. Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M & Singh-Manoux A. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 2013 36 2294-2300. (doi:10.2337/dc12-1654)
18. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ & Reis SE. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004 17 706-713. (doi:10.1161/01.CIR.0000115514.44135.A8)
19. Ärnlöv J, Ingelsson E, Sundström J & Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010 121 230-236. (doi:10.1161/CIRCULATIONAHA.109.887521)
20. Durward CM, Hartman TJ & Nickols-Richardson SM. All-cause mortality risk of metabolically healthy obese individuals in NHANES III. Journal of Obesity 2012 2012 460321. (doi:10.1155/2012/460321)
21. Choi KM, Cho HJ, Choi HY, Yang SJ, Yoo HJ, Seo JA, Kim SG, Baik SH, Choi DS & Kim NH. Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans. Clinical Endocrinology 2013 79 364-370. (doi:10.1111/cen.2013.79.issue-3)
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883)
23. Matsuda M & DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999 22 1462-1470.
24. Twisk J, Smidt N & de Vente W. Applied analysis of recurrent events: a practical overview. Journal of Epidemiology and Community Health 2005 59 706. (doi:10.1136/jech.2004.030759)
25. Andersen P & Gill R. Cox's regression model for counting processes: a large sample study. Annals of Statistics 1982 10 1100-1120.
26. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, Adams RJ & the North West Adelaide Health Study Team. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013 36 2388-2394. (doi:10.2337/dc12-1971)
27. Gómez-Ambrosi J, Catalán V, Rodríguez A, Andrada P, Ramírez B, Ibzáñez P, Vila N, Romero S, Margall MA, Gil MJ et al. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care 2014 37 2813-2821. (doi:10.2337/dc14-0937)
28. The Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, Sarwar N, Kizer JR, Lawlor DA et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011 377 1085-1095. (doi:10.1016/S0140-6736(11)60105-0)
29. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM & D'Agostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 2006 91 2906-2912. (doi:10.1210/jc.2006-0594)
30. Soriguer F, Gutiérrez-Repiso C, Rubio-Martín E, García-Fuentes E, Almaraz MC, Colomo N, Esteva de Antonio I, de Adana MS, Chaves FJ, Morcillo S et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. Journal of Clinical Endocrinology and Metabolism 2013 98 2318-2325. (doi:10.1210/jc.2012-4253)
31. Godsland IF. Intra-individual variation: significant changes in parameters of lipid and carbohydrate metabolism in the individual and intra-individual variation in different test populations. Annals of Clinical Biochemistry 1985 22 618-624. (doi:10.1177/000456328502200612)
32. Katzmarzyk PT, Janssen I, Ross R, Church TS & Blair SN. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006 29 404-409. (doi:10.2337/diacare.29.02.06.dc05-1636)
33. Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE & Liu S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. American Journal of Cardiology 2007 100 1654-1658. (doi:10.1016/j.amjcard.2007.06.073)
34. St-Pierre AC, Cantin B, Mauriège P, Bergeron J, Dagenais GR, Després JP & Lamarche B. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. Canadian Medical Association Journal 2005 172 1301-1305. (doi:10.1503/cmaj.1040834)
35. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, Mannino S, Crosignani P, Bosi E, Luzi L et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011 34 210-215. (doi:10.2337/dc10-0665)
36. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U & Wildman RP. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity 2012 20 651-659. (doi:10.1038/oby.2011.243)
37. Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC & Rimm EB. Excess weight and the risk of incident coronary heart disease among men and women. Obesity 2010 18 377-383. (doi:10.1038/oby.2009.223)